Redwood Wealth Management Group, LLC Acumen Pharmaceuticals, Inc. Transaction History
Redwood Wealth Management Group, LLC
- $133 Billion
- Q2 2024
A detailed history of Redwood Wealth Management Group, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Redwood Wealth Management Group, LLC holds 800 shares of ABOS stock, worth $2,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800Holding current value
$2,080% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
41.9MCall Options Held
239KPut Options Held
65.9K-
Ra Capital Management, L.P. Boston, MA14.9MShares$38.8 Million0.54% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$8.88 Million4.16% of portfolio
-
Franklin Resources Inc San Mateo, CA3.37MShares$8.76 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$5.98 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$5.61 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $105M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...